Are We Going to Have an Immortality Drug?

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

I'm not quite sure what will actually happen. I think it will become a lot more vivid when people do start, the rich people do start living a lot longer. What we really hope though is that if you were to find something that every person could take, would be relatively inexpensive and help them avoid something like cardiovascular disease or diabetes. And i know that that other train e other thought, is that you can have some oy live er. I just, i'm not sure that w ever get there. Adi think that's ok. I just wanted to sort of, a, let ourselves go wild.

Aging -- everybody does it, very few people actually do something about it. Coleen Murphy is an exception. In her laboratory at Princeton, she and her team study aging in the famous C. Elegans roundworm, with an eye to extending its lifespan as well as figuring out exactly what processes take place when we age. In this episode we contemplate what scientists have learned about aging, and the prospects for ameliorating its effects -- or curing it altogether? -- even in human beings. Coleen Murphy received her Ph.D. in biochemistry from Stanford University, and is currently Professor in the Department of Molecular Biology and the Lewis-Sigler Institute of Integrative Genomics at Princeton. Home page at the Lewis-Sigler Institute Lab web page Princeton Profile Google Scholar publication page Twitter See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.